Hillmar I et al. |
Effects of a thio analog of platelet-activating factor on platelet aggregation and adenosine 3',5'-monophosphate concentration in hepatocyte suspensions and in platelets. A comparison with the naturally occurring compound. |
1984 |
Hoppe-Seyler's Z. Physiol. Chem. |
pmid:6325321
|
Valone FH |
Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine. |
1984 |
Immunology |
pmid:6325330
|
Lefort J et al. |
The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. |
1984 |
Br. J. Pharmacol. |
pmid:6430375
|
Kamitani T et al. |
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine. |
1984 |
Eur. J. Pharmacol. |
pmid:6144557
|
Tokumura A et al. |
Contractile effect of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine on strips of isolated rat intestine. |
1984 |
J. Pharm. Pharmacol. |
pmid:6144763
|
Pirotzky E et al. |
Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys. |
1984 |
Kidney Int. |
pmid:6144811
|
Gómez-Cambronero J et al. |
The role of calcium ions in the process of acetyltransferase activation during the formation of platelet-activating factor (PAF-acether). |
1984 |
Biochem. J. |
pmid:6146309
|
Morley J et al. |
The platelet in asthma. |
1984 |
Lancet |
pmid:6150192
|
Dahlbäck M et al. |
Bronchial anaphylaxis in actively sensitized Sprague Dawley rats: studies on mediators involved. |
1984 |
Acta Pharmacol Toxicol (Copenh) |
pmid:6431753
|
Rao AK et al. |
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. |
1984 |
Am. J. Hematol. |
pmid:6431801
|
Siess W et al. |
Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. |
1984 |
J. Biol. Chem. |
pmid:6429141
|
Malpass TW et al. |
The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass. |
1984 |
J. Thorac. Cardiovasc. Surg. |
pmid:6231433
|
Willoughby WF and Willoughby JB |
Immunologic mechanisms of parenchymal lung injury. |
1984 |
Environ. Health Perspect. |
pmid:6234162
|
Dewar A et al. |
Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. |
1984 |
J. Pathol. |
pmid:6481526
|
Goldstein BM et al. |
Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat. |
1984 |
Life Sci. |
pmid:6482659
|
Baldo BA and Tovey ER |
Allergy, allergens and allergen standardization. |
1984 |
Med. J. Aust. |
pmid:6482786
|
Saeki S et al. |
Effect of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine on blood pressure by intra-lateral ventricular injection in the rat. |
1984 |
Med J Osaka Univ |
pmid:6482814
|
Nishizawa EE and Della-Coletta AA |
The formation of a thrombin-like material (TLM) following stimulation of leukocytes. |
1984 |
Thromb. Res. |
pmid:6484896
|
Lenihan DJ and Lee TC |
Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6732789
|
Kasuya Y et al. |
Hypotensive actions of some analogues of platelet-activating factor (PAF) with higher potencies than natural PAF. |
1984 |
Can. J. Physiol. Pharmacol. |
pmid:6733593
|
Page CP et al. |
Platelets and bronchospasm. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6735490
|
Jouvin-Marche E et al. |
Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. |
1984 |
J. Immunol. |
pmid:6736649
|
|
Renal syndromes and nonsteroidal antiinflammatory drugs. |
1984 |
N. Engl. J. Med. |
pmid:6738607
|
Bottecchia D et al. |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. |
1984 |
Scand J Haematol |
pmid:6695148
|
Blank ML et al. |
A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6696762
|
Williams KA and Haslam RJ |
Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor). |
1984 |
Biochim. Biophys. Acta |
pmid:6696908
|
Hoffman DR et al. |
Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts. |
1984 |
Blood |
pmid:6696992
|
Kasuya Y et al. |
Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF). |
1984 |
J. Pharmacobio-dyn. |
pmid:6726619
|
Beaubien BB et al. |
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6594998
|
Roubin R et al. |
The role of immunomodulators in the production of lipid mediators by macrophages (M phi). |
1984 |
Int J Tissue React |
pmid:6596298
|
Archer CB et al. |
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin. |
1984 |
Br. J. Dermatol. |
pmid:6581831
|
O'Neill C and Saunders DM |
Assessment of embryo quality. |
1984 |
Lancet |
pmid:6149413
|
Gunby P |
A new piece for the puzzle of inflammation. |
1984 |
JAMA |
pmid:6420583
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|
Billah MM and Siegel MI |
Calmodulin antagonists inhibit formation of platelet-activating factor in stimulated human neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6422930
|
Prevost MC et al. |
Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6422938
|
Wodzinowska B and Krajewski T |
[Role of blood platelets and their membrane in the process of hemostasis]. |
1984 Jan-Feb |
Postepy Hig Med Dosw |
pmid:6093087
|
Vemulapalli S et al. |
Cardiovascular and renal action of platelet-activating factor in anesthetized dogs. |
1984 Jul-Aug |
Hypertension |
pmid:6378787
|
Cox CP et al. |
VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). |
1984 Mar-Apr |
Peptides |
pmid:6206481
|
Barnes JL and Venkatachalam MA |
The role of platelets and polycationic mediators in glomerular vascular injury. |
1985 |
Semin. Nephrol. |
pmid:2957770
|
Shukla SD |
Platelet activating factor-stimulated formation of inositol triphosphate in platelets and its regulation by various agents including Ca2+, indomethacin, CV-3988, and forskolin. |
1985 |
Arch. Biochem. Biophys. |
pmid:3875314
|
Wasserman SI |
Mast cell mediators in the blood of patients with asthma. |
1985 |
Chest |
pmid:3880526
|
Halonen M et al. |
Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function. |
1985 |
Am. Rev. Respir. Dis. |
pmid:3881060
|
Moore TL and Weiss TD |
Mediators of inflammation. |
1985 |
Semin. Arthritis Rheum. |
pmid:3936177
|
Juhan-Vague I et al. |
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro. |
1985 |
Thromb. Res. |
pmid:3923649
|
Steiner M et al. |
Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3936503
|
Proll MA et al. |
Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein, Ni. |
1985 |
Mol. Pharmacol. |
pmid:2997592
|
MacIntyre DE et al. |
Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+. |
1985 |
Nouv Rev Fr Hematol |
pmid:2997706
|
Lachachi H et al. |
Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2998370
|
Hwang SB et al. |
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor. |
1985 |
J. Biol. Chem. |
pmid:2999126
|
Iñarrea P et al. |
Synthesis of PAF-acether and blood volume changes in gram-negative sepsis. |
1985 |
Immunopharmacology |
pmid:3886598
|
Lellouch-Tubiana A et al. |
Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. |
1985 |
Br J Exp Pathol |
pmid:3890915
|
Camussi G et al. |
The role of platelet-activating factor in experimental immune complex pathology. |
1985 |
Int J Tissue React |
pmid:2932406
|
Weber N and Mangold HK |
Semi-synthetic preparation of 1-O-[1'-14C]hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) using plant cell cultures. |
1985 |
J. Lipid Res. |
pmid:3891896
|
Hanahan DJ and Weintraub ST |
Platelet-activating factor isolation, identification, and assay. |
1985 |
Methods Biochem Anal |
pmid:3894881
|
Murer EH |
The role of platelet calcium. |
1985 |
Semin. Hematol. |
pmid:3901271
|
Davis JW et al. |
Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. |
1985 |
Clin. Pharmacol. Ther. |
pmid:3987176
|
O'Neill C |
Examination of the causes of early pregnancy-associated thrombocytopenia in mice. |
1985 |
J. Reprod. Fertil. |
pmid:3989801
|
Benveniste J |
Biosynthesis and function of PAF-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936197
|
Kertscher HP and Ostermann G |
[Synthesis and biological activity of isomeric structural analogs of platelet activating factor]. |
1985 |
Pharmazie |
pmid:3991788
|
Billah MM et al. |
Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2. |
1985 |
J. Biol. Chem. |
pmid:3922982
|
Detsouli A et al. |
Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether. |
1985 |
Br. J. Pharmacol. |
pmid:4005486
|
Korth R et al. |
Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines (unsaturated platelet-activating factor): aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release after incubation with indomethacin. |
1985 |
Chem. Phys. Lipids |
pmid:4006034
|
Shigenobu K et al. |
Platelet activating factor analogues: lack of correlation between their activities to produce hypotension and endothelium-mediated vasodilation. |
1985 |
J. Pharmacobio-dyn. |
pmid:4009403
|
Saeki S et al. |
Effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on cardiac function in perfused guinea-pig heart. |
1985 |
Life Sci. |
pmid:4010479
|
Nunn B et al. |
Effect of temocillin and moxalactam on platelet responsiveness and bleeding time in normal volunteers. |
1985 |
Antimicrob. Agents Chemother. |
pmid:4015075
|
Weintraub ST et al. |
Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:4015656
|
Archer CB et al. |
Inflammatory cell accumulation in response to intracutaneous Paf-acether: a mediator of acute and persistent inflammation? |
1985 |
Br. J. Dermatol. |
pmid:4015978
|
Morley J et al. |
The role of circulating cells in skin reactions. |
1985 |
Br. J. Dermatol. |
pmid:4015983
|
Pirotzky E et al. |
A role for Paf-acether (platelet-activating factor) in acute skin inflammation? |
1985 |
Br. J. Dermatol. |
pmid:4015984
|
Ohno M et al. |
An enantioselective synthesis of platelet-activating factors, their enantiomers, and their analogues from D- and L-tartaric acids. |
1985 |
Chem. Pharm. Bull. |
pmid:4017109
|
Yousufzai SY and Abdel-Latif AA |
Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists. |
1985 |
Biochem. J. |
pmid:3927898
|
Suemune H et al. |
Synthetic studies on platelet-activating factor (PAF). |
1985 |
Chem. Pharm. Bull. |
pmid:4028291
|
Parente L et al. |
The release of lyso-PAF from guinea-pig lungs. |
1985 |
Eur. J. Pharmacol. |
pmid:4029263
|
MacIntyre DE et al. |
Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets. |
1985 |
FEBS Lett. |
pmid:2981715
|
Meloni Bruneri LH and Barbieri D |
[Platelet aggregation after the reduction of nitro-blue tetrazolium by eosinophils]. |
1985 |
Sangre (Barc) |
pmid:4071355
|
Söling HD et al. |
Regulation of protein kinases in exocrine secretory cells during agonist-induced exocytosis. |
1985 |
Adv. Enzyme Regul. |
pmid:4072796
|
Mushayakarara EC and Mantsch HH |
Thermotropic phase behavior of the platelet-activating factor: an infrared spectroscopic study. |
1985 |
Can. J. Biochem. Cell Biol. |
pmid:4075223
|
Zimmerman GA et al. |
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. |
1985 |
J. Clin. Invest. |
pmid:4077977
|
Young JM et al. |
Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse. |
1985 |
Prostaglandins |
pmid:4081060
|
|
Is there a case for PAF-acether antagonists? Institut Pasteur, Paris, 21 June 1985. Abstracts. |
1985 |
Prostaglandins |
pmid:4081064
|
Valone FH and Johnson B |
Decay of the activating signal after platelet stimulation with 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine: changes in calcium permeability. |
1985 |
Thromb. Res. |
pmid:4082115
|
Scherer GF |
1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) stimulates plant H+ transport in vitro and growth. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:4084306
|
Handley DA et al. |
Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig. |
1985 |
Thromb. Haemost. |
pmid:4089809
|
Hemker HC and Béguin S |
The generation of thrombin in whole plasma. Biochemical possibilities and physiological realities. |
1985 |
Verh. K. Acad. Geneeskd. Belg. |
pmid:4090648
|
Vigo C |
Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. |
1985 |
J. Biol. Chem. |
pmid:3919022
|
Armstrong RA et al. |
Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha. |
1985 |
Prostaglandins |
pmid:2988022
|
Cox CP |
Activation of washed chicken thrombocytes by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (platelet-activating factor). |
1985 |
Comp Biochem Physiol A Comp Physiol |
pmid:2864195
|
Dewald B and Baggiolini M |
Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2985075
|
Peach MJ et al. |
Mechanisms of endothelium-dependent vascular smooth muscle relaxation. |
1985 |
Biochem. Pharmacol. |
pmid:2988558
|
Braquet M et al. |
Leukocytic functions in burn-injured patients. |
1985 |
Prostaglandins |
pmid:2989978
|
Grandel KE et al. |
Association of platelet-activating factor with primary acquired cold urticaria. |
1985 |
N. Engl. J. Med. |
pmid:2410790
|
Bussolino F et al. |
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells. |
1985 |
J. Immunol. |
pmid:2411812
|
Johnson HM and Torres BA |
Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2412225
|
Tou J |
Platelet-activating factor promotes arachidonate incorporation into phosphatidylinositol and phosphatidylcholine in neutrophils. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3921017
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Avdonin PV and Altukhova IP |
[Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels]. |
1985 |
Biokhimiia |
pmid:2416359
|
Lee TD et al. |
Heterogeneity in mast cell populations. |
1985 |
Clin Immunol Rev |
pmid:2417770
|
Leclercq M et al. |
[Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings]. |
1985 |
Rev Med Liege |
pmid:2418479
|
Pipili E |
Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. |
1985 |
Thromb. Haemost. |
pmid:2418525
|